title: Molecular diagnostics: a healthcare perspective.
abstract: Recent progress in the development of molecular diagnostics in medicine has been rapid and the hope has been expressed by some people that it will soon be possible to have a detailed 'genetic readout' to assist in the diagnosis of treatment of a variety of diseases. However, such an outcome may be neither achievable nor desirable when viewed from the perspective of suppliers of healthcare.
authors.affiliation: Leukaemia Research Fund Laboratory, Northern Institute for Cancer Research, Medical School, Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK. a.g.hall@ncl.ac.uk
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Hall
authors.forename: Sally A
authors.initials: SA
authors.lastname: Coulthard
authors.forename: Julie A E
authors.initials: JA
authors.lastname: Irving
mesh_terms: D003362:Cost-Benefit Analysis / Q000191:economics / Q000639:trends; D003695:Delivery of Health Care / Q000191:economics; D004992:Ethics, Medical; D019317:Evidence-Based Medicine; D006801:Humans; D025202:Molecular Diagnostic Techniques; D006113:United Kingdom